Correlation Between GlaxoSmithKline PLC and Ladenburg Aggressive

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Ladenburg Aggressive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Ladenburg Aggressive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Ladenburg Aggressive Growth, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Ladenburg Aggressive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Ladenburg Aggressive. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Ladenburg Aggressive.

Diversification Opportunities for GlaxoSmithKline PLC and Ladenburg Aggressive

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Ladenburg is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Ladenburg Aggressive Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ladenburg Aggressive and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Ladenburg Aggressive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ladenburg Aggressive has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Ladenburg Aggressive go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Ladenburg Aggressive

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 43.4 times less return on investment than Ladenburg Aggressive. In addition to that, GlaxoSmithKline PLC is 1.64 times more volatile than Ladenburg Aggressive Growth. It trades about 0.0 of its total potential returns per unit of risk. Ladenburg Aggressive Growth is currently generating about 0.08 per unit of volatility. If you would invest  1,483  in Ladenburg Aggressive Growth on August 27, 2024 and sell it today you would earn a total of  535.00  from holding Ladenburg Aggressive Growth or generate 36.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Ladenburg Aggressive Growth

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Ladenburg Aggressive 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ladenburg Aggressive Growth are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak fundamental indicators, Ladenburg Aggressive may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Ladenburg Aggressive Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Ladenburg Aggressive

The main advantage of trading using opposite GlaxoSmithKline PLC and Ladenburg Aggressive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Ladenburg Aggressive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ladenburg Aggressive will offset losses from the drop in Ladenburg Aggressive's long position.
The idea behind GlaxoSmithKline PLC ADR and Ladenburg Aggressive Growth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital